Brief: Taysha Gene Therapies Reports First Quarter 2022 Financial Results

Taysha Gene Therapies

16/05/2022 12:12

May 16 (Reuters) - Taysha Gene Therapies Inc  TSHA.O :
    * TAYSHA GENE THERAPIES REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * AS OF MARCH 31, 2022, WE HAD $96.6 MILLION IN CASH AND
CASH
EQUIVALENTS
    * TAYSHA GENE-EXISTING CASH, CASH EQUIVALENTS, FULL ACCESS
TO TERM
LOAN FACILITY, EXPECTED TO FUND OPERATING EXPENSES, CAPITAL
REQUIREMENTS INTO Q4 2023
    * NET LOSS FOR THREE MONTHS ENDED MARCH 31, 2022 WAS $1.31
PER
SHARE
    * Q1 EARNINGS PER SHARE VIEW $-1.07 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX14Tkhm 
Further company coverage:  TSHA.O 

 ((Reuters.Briefs@thomsonreuters.com;))